Undertreatment in a nonselected population of adult patients with asthma

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 3, 1996, Pages 514-521

  Bousquet, Jean ^a   Knani, Jalel ^a   Henry, Christine ^b   Liard, Renata ^b   Richard, Alain ^c   Michel, François B ^a   Neukirch, Françoise ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b INSERM   (France)

^c Laboratoire Glaxo Wellcome   (France)

Author keywords

Asthma; epidemiology; undertreatment

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; METHACHOLINE; NEDOCROMIL SODIUM;

ADULT; ARTICLE; ASTHMA; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; QUESTIONNAIRE; SCORING SYSTEM;

EID: 0029914052     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70084-2     Document Type: Article

References (60)

1. Burney PG, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86. BMJ 1990;300:1306-10.
2. Benatar SR, Ainslie GM. Deaths from asthma in Cape Town, 1980-1982. S Afr Med J 1986;69:669-71.
3. Bloomberg GR, Strunk RC. Crisis in asthma care. Pediatr Clin North Am 1992;39:1225-41.
4. Bauman A, Mitchell CA, Henry RL, et al. Asthma morbidity in Australia: an epidemiological study. Med J Aust 1992;156:827-31.
5. Buist AS. Is asthma mortality increasing? Chest 1988;93: 449-50.
6. Sears MR. Worldwide trends in asthma mortality. Bull Int Union Tuberc Lung Dis 1991;66:79-83.
7. Woolcock A, Rubinfield A, Searle J, et al. Asthma management plan. Med J Aust 1989;151:650-2.
8. Hill RA, Standen PJ, Tattersfield AE. Asthma, wheezing, and school absence in primary schools. Arch Dis Child 1989;64:246-51.
9. Rea HH, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland DC. A case-control study of deaths from asthma. Thorax 1986;41:833-9.
10. Hargreave FE, Dolovich J. Newhouse MT. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol 1990;85:1098-111.
11. Warner J, Götz MG, Landau L, et al. Management of asthma: a consensus statement. Arch Dis Child 1989;64: 1065-79.
12. Guidelines for management of asthma in adults: I - Chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. BMJ 1990;301:651-3.
13. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol 1991;88:425-534.
14. International Consensus Report on Diagnosis and Management of Asthma. International Asthma Management Project. Allergy 1992;47:1-61.
15. McFadden E Jr, Gilbert IA. Asthma. N Engl J Med 1992;327:1928-37.
16. van-Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Nonspecific Lung Disease Study Group. Am Rev Respir Dis 1992;146:547-54.
17. Haahtela T, Jarvinen M, Kava T, et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-92.
18. Sears MR, Taylor DR, Print CG, Lake DC, Herbison GP, Flannery EM. Increased inhaled bronchodilator vs increased inhaled corticosteroid in the control of moderate asthma. Chest 1992;102:1709-15.
19. Waalkens HJ, Van-Essen-Zandvliet EE, Hughes MD, et al. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group. Am Rev Respir Dis 1993;148:1252-7.
20. Waalkens HJ, van-Essen-Zandvliet EE, Gerritsen J, Duiverman EJ, Kerrebijn KF, Knol K. The effect of an inhaled corticosteroid (budesonide) on exercise-induced asthma in children. Dutch CNSLD Study Group. Eur Respir J 1993;6: 652-6.
21. Speight AN, Lee DA, Hey EN. Underdiagnosis and undertreatment of asthma in childhood. Br Med J Clin Res 1983;286:1253-6.
22. Kaptein AA, Dekker FW, Gill K, van-der-Waart MA. Undertreatment of asthma in Dutch general practice. Fam Pract 1987;4:219-25.
23. Bauman A, Young L, Peat JK, Hunt J, Larkin P. Asthma under-recognition and under-treatment in an Australian community. Aust N Z J Med 1992;22:36-40.
24. Neville RG, Bryce FP, Robertson FM, Crombie IK, Clark RA. Diagnosis and treatment of asthma in children: usefulness of a review of medical records. Br J Gen Pract 1992;42:501-3.
25. Cochrane GM, Horn CR. The management of asthma in the community: problems of compliance with treatment. Q J Med 1991;81:797-8.
26. Hargreave FE, Sterk P, Adelroth EC, Ramsdale EH, O'Byrne PM. Airway responsiveness to histamine or methacholine: advances in measurement and interpretation. Respiration 1986;2:72-6.
27. Woolcock AJ, Salome CM, Yan K. The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis 1984;130:71-5.
28. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness. Standardized challenge testing with pharmacolog-ical, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:53-83.
29. Dekker FW, Schrier AC, Sterk PJ, Dijkman JH. Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax 1992;47:162-6.
30. Brand PL, Kerstjens HA, Postma DS, et al. Long-term multicentre trial in chronic nonspecific lung disease: methodology and baseline assessment in adult patients. Dutch CNSLD Study Group. Eur Respir J 1992;5:21-31.
31. Aas K. Heterogeneity of bronchial asthma. Allergy 1981;36:3-10.
32. Archer LN, Simpson H. Night cough counts and diary card scores in asthma. Arch Dis Child 1985;60:473-4.
33. Strub M, Frey C Jr, Waskerwitz S, Unfer S, Luskin AT, Chudwin DS. Clinical assessment score and peak expiratory flow rate. Correlation in acute childhood asthma. IMJ 1986; 170:30-2.
34. Becker AB, Nelson NA, Simons FE. The pulmonary index. Assessment of a clinical score for asthma. Am J Dis Child 1984;138:574-6.
35. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
36. Bousquet J, Chanez P, Lacoste JY, et al. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol 1991;88:649-60.
37. Cluzel M, Damon M, Chanez P, et al. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol 1987;80:195-201.
38. Robinson DS, Ying S, Bentley AM, et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993;92:397-403.
39. Vignola AM, Campbell AM, Chanez P, et al. HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis 1993;148:689-94.
40. Bousquet J, Knani J. Dhivert H, et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994;149:371-5.
41. The European Community Respiratory Health Survey. Medicine and Health. Luxembourg: Europena Commission, Directorate General XIII, Office for Official Publications. L-2920 1994.
42. Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994; 7:954-60.
43. Burney P, Chinn S. Developing a new questionnaire for measuring the prevalence and distribution of asthma. Chest 1987;91:79S-83S.
44. Abramson MJ, Hensley MJ, Saunders NA, Wlodarczyk JH. Evaluation of a new asthma questionnaire. J Asthma 1991;28:129-39.
45. Burney PG, Laitinen LA, Perdrizet S, et al. Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J 1989;2:940-5.
46. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978;118:1-120.
47. US Public Health Service. Smoking and health. Public Health Review: 1979. Washington (DC): US Department of Health, Education, and Welfare, 1979. US Dept of Health, Education, and Welfare publication number (PHS)79-50066.
48. Samet J. The relationship of smoking to COPD. In: Cherniak N, ed. Chronic obstructive pulmonary disease. Philadelphia: WB Saunders Company, 1991:249-58.
49. Salome CM, Peat JK, Britton WJ, Woolcock AJ. Bronchial hyperresponsiveness in two populations of Australian schoolchildren. I. Relation to respiratory symptoms and diagnosed asthma. Clin Allergy 1987;17:271-81.
50. Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982;37:423-9.
51. Josephs LK, Gregg I, Mullee MA, Holgate ST. Nonspecific bronchial reactivity and its relationship to the clinical expression of asthma. A longitudinal study. Am Rev Respir Dis 1989;140:350-7.
52. Josephs LK, Gregg I, Mullee MA, Campbell MJ, Holgate ST. A longitudinal study of baseline FEV1 and bronchial responsiveness in patients with asthma. Eur Respir J 1992;5:32-9.
53. Pattemore PK, Asher MI, Harrison AC, Mitchell EA. Rea HH, Stewart AW. The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms. Am Rev Respir Dis 1990;142:549-54.
54. Spector S, Farr R. A comparison of methacholine and histamine inhalations in asthmatics. J Allergy Clin Immunol 1975;56:306-18.
55. Cockcroft D, Killian D, Mellon J, Hargreave F. Bronchial reactivity to inhaled histamine: a method and clinical severity. Clin Allergy 1977;7:235-43.
56. Juniper EF, Frith PA, Hargreave FE. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981;36:575-9.
57. Woolcock AJ, Salome CM, Keena VA. Reducing the severity of bronchial hyperresponsiveness. Am Rev Respir Dis 1991;143:S75-7.
58. Adelroth E, Rosenhall L, Glennow C. High dose inhaled budesonide in the treatment of severe steroid-dependent asthmatics. A two-year study. Allergy 1985;40:58-64.
59. Young L, Forero R, Bauman A, Larkin P. Sampling bias in asthma surveys of patients attending general practitioners in south-western Sydney. Aust Fam Physician 1992;21: 862-3.
60. Dompeling E. van-Schayck CP, van-Grunsven PM, et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med 1993;118:770-8.